Search for dissertations about: "CD56"
Showing result 16 - 20 of 23 swedish dissertations containing the word CD56.
-
16. Maternal microchimerism
Abstract : Microchimerism refers to one individual harboring cells or DNA at a low level that derive from another individual. The most common source is pregnancy when cells from the fetus and the mother pass the placenta bidirectionally, and give rise to maternal microchimerism (cells from the mother in the fetus) and fetal microchimerism (cells from the fetus in the mother). READ MORE
-
17. Sex differences in immune response and sex hormone receptor expression in healthy individuals and during viral infection
Abstract : There is sex-bias in morbidity and mortality from infectious diseases. Infections kill more men than women and several studies have pointed out differences in the immune system as a reason. The sex hormones estrogen, progesterone and testosterone all shape the effect of the immune response on multiple levels. READ MORE
-
18. Innate-like T cells in the immunopathogenesis of HIV-1 infection
Abstract : The immunodynamics of HIV infection have been studied for over three decades in the hopes of determining underlying mechanisms that contribute to the sustained immune dysfunction observed even in individuals on therapy. Conventional and adaptive T cells are both the target of the virus and considered the main players in controlling viral burden. READ MORE
-
19. The Immune System in the Oldest-Old : Clinical and Immunological Studies in the NONA Immune Cohort
Abstract : The oldest-old (people aged 80 or older) constituted 5 % of the population in Sweden in 2000, an increase from 1.5 % fifty years earlier. The immune system undergoes dramatic changes at high age, sometimes referred to as “immunosenescence”. READ MORE
-
20. Outcome after allogeneic stem cell transplantation with special reference to non-malignant disorders, chimerism and graft cell composition
Abstract : The outcome for patients undergoing allogeneic stem cell transplantation (HSCT), a treatment for several severe malignant and non-malignant disorders with hematopoietic origin, is a balancing act between beneficiary effects and risk factors. Treatment success is still limited by excessive immune response, such as graft-versus-host–disease (GVHD) and graft failure (GF), or the lack thereof as in malignancy relapse or severe infections. READ MORE